Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

3,897 total articles

Applied Materials, Rivian and Pinterest Lead Wide Swings in Market-Cap Winners and Losers

Applied Materials, Rivian and Pinterest Lead Wide Swings in Market-Cap Winners and Losers

Friday's trading session produced sharp moves across market-cap segments as analyst upgrades, earnings prints and guidance updates pushed some names sharply higher and others notably lower. Applied Materials and Rivian posted strong gains after positive analyst actions, while Pinterest and several mid- and small-cap names slumped following downgrad…

Istanbul stocks nudge higher at Friday close as select sectors lead gains

Istanbul stocks nudge higher at Friday close as select sectors lead gains

Turkish equity trading on Friday closed with gains driven by the Transport, Information Technology and Real Estate Investments sectors. The BIST 100 registered a rise of 0.00% to reach a fresh all-time high. Several small- and mid-cap names posted double-digit percentage moves, while headline breadth showed more advancing issues than decliners. Com…

Anthropic Adds Chris Liddell to Board as IPO Talk Intensifies

Anthropic Adds Chris Liddell to Board as IPO Talk Intensifies

Anthropic has named Chris Liddell, a former Microsoft and General Motors executive, to its board of directors. The appointment comes as the developer of the Claude chatbot signals to partners that it may pursue an initial public offering by the end of 2026. Liddell brings experience from GM’s post-bankruptcy IPO effort and prior government service.

Craig-Hallum Start Boosts Compass Therapeutics Shares as Analyst Flags Commercial Path for Lead BsAb

Craig-Hallum Start Boosts Compass Therapeutics Shares as Analyst Flags Commercial Path for Lead BsAb

Compass Therapeutics (CMPX) shares rose after Craig-Hallum initiated coverage with a Buy rating and a $15.00 price target, citing confidence in the company’s bispecific antibody strategy and a near-term commercial opportunity for lead candidate tovecimig in second-line biliary tract cancer. The firm also highlighted early-stage programs positioned …

Deutsche Bank Turns Positive on Rivian as UBS Stays Cautious

Deutsche Bank Turns Positive on Rivian as UBS Stays Cautious

Major brokerages issued contrasting views on Rivian on Friday. Deutsche Bank raised its rating to Buy and lifted its price target, citing signs of an improving trajectory, better vehicle costs and a clearer 2026 outlook. UBS moved to Neutral from Sell, saying the company’s path to scale and profitability remains uncertain amid cash burn and executi…

Goldman Sachs Chief Legal Officer Kathy Ruemmler Resigns After DOJ Documents; CEO Says He 'Reluctantly Accepted' Decision

Goldman Sachs Chief Legal Officer Kathy Ruemmler Resigns After DOJ Documents; CEO Says He 'Reluctantly Accepted' Decision

Goldman Sachs CEO David Solomon said he had "reluctantly accepted" the resignation of Chief Legal Officer Kathy Ruemmler and emphasized his respect for her decision. The exit follows Justice Department documents indicating Ruemmler accepted gifts from Jeffrey Epstein and counseled him on responding to media inquiries about his crimes. Her departure…

BMO Lowers Rating on Dollar Tree, Citing Digital Shortfalls and Margin Risks

BMO Lowers Rating on Dollar Tree, Citing Digital Shortfalls and Margin Risks

BMO Capital Markets downgraded Dollar Tree to Underperform from Market Perform and trimmed its price target to $95, saying the stock's valuation and earnings outlook look stretched given gaps in digital strategy and risks to margin expansion. The bank applied a lower multiple to a below-consensus earnings forecast for fiscal 2027 and flagged potent…